KTTA - Pasithea Therapeutics Corp
Previous close
4.7104
0 0%
Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.71
0.00
0.00%
Summary score
14%
Profitability
6%
Dept financing
2%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.93%
Return on assets
-8.62%
Return on sales
-11085.01%
Return on invested capital
17.62%
Total debt ratio
5.4%
Debt ratio change over timeo
-1.08%
Current Ratio
36.22%
Quick Ratio
36.22%
Cash Position Ratio
35.4%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.1%
Return on assets
-10.32%
Return on sales
-2110.77%
Return on invested capital
-47.36%
Total debt ratio
6.75%
Debt ratio change over timeo
-1.11%
Current Ratio
13.89%
Quick Ratio
13.89%
Cash Position Ratio
13.32%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-12.73%
Return on assets
-12.36%
Return on sales
0%
Return on invested capital
-46.07%
Total debt ratio
7.45%
Debt ratio change over time
-0.99%
Current Ratio
10.16%
Quick Ratio
10.16%
Cash Position Ratio
9.58%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.39%
Return on assets
-87.2%
Return on sales
12305.86%
Return on invested capital
-109.51%
Total debt ratio
-108.25%
Debt ratio change over time
-1.08%
Current Ratio
-50.67%
Quick Ratio
-50.67%
Cash Position Ratio
-49.44%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KTTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.93% | 7.58% | 36.15% | 7.75% |
| Return on assets | -8.62% | 2.95% | 3.44% | 5.85% |
| Return on sales | -11085.01% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 17.62% | 3.7% | 6.05% | 20.44% |
| Profitability | 22% | 41% | 68% | 80% |
| Total debt ratio | 5.4% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -1.08% | 292.67% | 15.45% | 1.02% |
| Dept financing | 1% | 50% | 25% | 7% |
| Current Ratio | 13.89% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 13.89% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 13.32% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 2% | 3% | 7% |
| Short-term ratios | KTTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.1% | 11.57% | 35.05% | 4.21% |
| Return on assets | -10.32% | 2.86% | 2.7% | 3.6% |
| Return on sales | -2110.77% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -47.36% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 6.75% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -1.11% | 102.83% | 13.09% | 1.3% |
| Dept financing | 2% | 49% | 28% | 6% |
| Current Ratio | 13.89% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 13.89% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 13.32% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 4% | 12% | 23% |